These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22471840)

  • 1. Cosmetic efficacy evaluation of an anti-acne cream using the 3D image analysis system.
    Choi KM; Kim SJ; Baek JH; Kang SJ; Boo YC; Koh JS
    Skin Res Technol; 2012 May; 18(2):192-8. PubMed ID: 22471840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and histological evaluation of 1% nadifloxacin cream in the treatment of acne vulgaris in Korean patients.
    Jung JY; Kwon HH; Yeom KB; Yoon MY; Suh DH
    Int J Dermatol; 2011 Mar; 50(3):350-7. PubMed ID: 21342170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study.
    Marcinkiewicz J; Wojas-Pelc A; Walczewska M; Lipko-Godlewska S; Jachowicz R; Maciejewska A; Białecka A; Kasprowicz A
    Eur J Dermatol; 2008; 18(4):433-9. PubMed ID: 18573718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evidence on the efficacy and safety of an antioxidant optimized 1.5% salicylic acid (SA) cream in the treatment of facial acne: an open, baseline-controlled clinical study.
    Zheng Y; Wan M; Chen H; Ye C; Zhao Y; Yi J; Xia Y; Lai W
    Skin Res Technol; 2013 May; 19(2):125-30. PubMed ID: 23331850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortexolone 17α-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris. A pilot randomized, double-blind comparative study vs. placebo and tretinoin 0·05% cream.
    Trifu V; Tiplica GS; Naumescu E; Zalupca L; Moro L; Celasco G
    Br J Dermatol; 2011 Jul; 165(1):177-83. PubMed ID: 21428978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical effectiveness of a cosmetic skincare treatment for acne-prone skin: a clinical study.
    Bartenjev I; Oremović L; Rogl Butina M; Sjerobabski Masnec I; Bouloc A; Voda K; Šitum M
    Acta Dermatovenerol Alp Pannonica Adriat; 2011 Jun; 20(2):55-62. PubMed ID: 21993702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled study of a cosmetic treatment for mild acne.
    Capitanio B; Sinagra JL; Weller RB; Brown C; Berardesca E
    Clin Exp Dermatol; 2012 Jun; 37(4):346-9. PubMed ID: 22369176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of a moisturizing cream as adjunctive treatment to oral isotretinoin or topical tretinoin in the management of acne.
    Laquieze S; Czernielewski J; Rueda MJ
    J Drugs Dermatol; 2006; 5(10):985-90. PubMed ID: 17373148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cosmetic treatments and acne].
    Poli F
    Rev Prat; 2002 Apr; 52(8):859-62. PubMed ID: 12053795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical study on the effects of a cosmetic product on dermal extracellular matrix components using a high-resolution multiphoton tomograph.
    Bazin R; Flament F; Colonna A; Le Harzic R; Bückle R; Piot B; Laizé F; Kaatz M; König K; Fluhr JW
    Skin Res Technol; 2010 Aug; 16(3):305-10. PubMed ID: 20636999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne.
    Gollnick HP; Graupe K; Zaumseil RP
    Eur J Dermatol; 2001; 11(6):538-44. PubMed ID: 11701404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.
    Tanghetti E; Dhawan S; Green L; Ling M; Downie J; Germain MA; Kasteler JS; Kircik L; Oefelein MG; Draelos Z
    J Drugs Dermatol; 2011 Jul; 10(7):783-92. PubMed ID: 21720661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of whitening efficacy of cosmetic products using a human skin pigmentation spot model.
    Tian Y; Hoshino T; Chen CJ; E Y; Yabe S; Liu W
    Skin Res Technol; 2009 May; 15(2):218-23. PubMed ID: 19622131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical ALA PDT for the treatment of severe acne vulgaris.
    Wang XL; Wang HW; Zhang LL; Guo MX; Huang Z
    Photodiagnosis Photodyn Ther; 2010 Mar; 7(1):33-8. PubMed ID: 20230991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study on efficacy treatment of acne vulgaris using a new method: results of a randomized double-blind trial with Acne Dressing.
    Chao CM; Lai WY; Wu BY; Chang HC; Huang WS; Chen YF
    J Cosmet Sci; 2006; 57(2):95-105. PubMed ID: 16688374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiant near infrared light emitting Diode exposure as skin preparation to enhance photodynamic therapy inflammatory type acne treatment outcome.
    Barolet D; Boucher A
    Lasers Surg Med; 2010 Feb; 42(2):171-8. PubMed ID: 20166163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of irritative potential of nadifloxacin 1% when combined with other topical anti-acne agents.
    Wilhelm KP; Wilhelm D; Neumeister C; Zsolt I; Schwantes U
    Clin Exp Dermatol; 2012 Mar; 37(2):112-7. PubMed ID: 22103435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.